HomeSLNO • NASDAQ
add
Soleno Therapeutics Inc
Previous close
$41.17
Day range
$40.68 - $42.43
Year range
$3.69 - $53.82
Market cap
1.43B USD
Avg Volume
505.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 23.07M | 182.42% |
Net income | -21.40M | -156.08% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -22.58M | -194.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 149.63M | 1,800.27% |
Total assets | 168.84M | 764.28% |
Total liabilities | 25.45M | 50.63% |
Total equity | 143.39M | — |
Shares outstanding | 33.34M | — |
Price to book | 9.57 | — |
Return on assets | -33.01% | — |
Return on capital | -38.25% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -21.40M | -156.08% |
Cash from operations | -12.53M | -86.21% |
Cash from investing | -115.24M | — |
Cash from financing | 938.00K | — |
Net change in cash | -126.83M | -1,785.17% |
Free cash flow | -11.94M | -228.97% |
About
Founded
1999
Headquarters
Website
Employees
33